Table 2.
Beta estimate | SE | df | t | 95% CI | p | |
---|---|---|---|---|---|---|
Model 1. Distance Traveled | ||||||
Age | -0.011 | 0.035 | 19.776 | -0.330 | -0.083 to 0.061 | 0.745 |
Phase† | ||||||
BL Phase | -0.382 | 0.145 | 2000.185 | -2.640 | -0.666 to -0.098 | 0.008 |
FU Phase | -0.404 | 0.153 | 1999.918 | -2.635 | -0.704 to -0.103 | 0.008 |
Function | 0.593 | 0.230 | 20.280 | 2.583 | 0.115 to 1.072 | 0.018 |
Function * BL Phase | -0.023 | 0.065 | 1998.153 | -0.355 | -0.151 to 0.105 | 0.723 |
Function * FU Phase | -0.082 | 0.072 | 2001.004 | -1.130 | -0.224 to 0.060 | 0.259 |
Model 2. Distance threshold (2+SDs) | ||||||
Age | 0.002 | 0.002 | 19.708 | 0.971 | -0.002 to 0.005 | 0.343 |
Phase† | ||||||
BL Phase | -0.102 | 0.016 | 2010.424 | -6.506 | -0.133 to -0.071 | < 0.001 |
FU Phase | -0.070 | 0.017 | 2010.030 | -4.218 | -0.102 to -0.037 | < 0.001 |
Function | -0.016 | 0.011 | 22.470 | -1.454 | -0.039 to 0.007 | 0.160 |
Function * BL Phase | 0.019 | 0.007 | 2003.165 | 2.697 | 0.005 to 0.033 | 0.007 |
Function * FU Phase | 0.025 | 0.008 | 2013.183 | 3.134 | 0.009 to 0.040 | 0.002 |
NOTE. BL = Baseline; FU = Follow-up.
Phases were compared to the intervention (PAW) phase.